Corcept Therapeutics | CORT - Trade Creditors


Corcept Therapeutics reported $40.44M in Trade Creditors for its fiscal quarter ending in December of 2025.





Trade Creditors Change Date
Acadia Pharmaceuticals USD 10.9M 10.84M Dec/2025
Alaunos Therapeutics USD 843K 34K Sep/2025
ANI Pharmaceuticals USD 62.58M 7.21M Dec/2025
Ardelyx USD 18.39M 3.29M Sep/2025
Assertio Holdings USD 14.66M 3.81M Sep/2025
Aurora Cannabis CAD 49.34M 31.94M Sep/2025
BioMarin Pharmaceutical USD 759.03M 39.41M Dec/2025
Bristol-Myers Squibb USD 4.29B 1.14B Sep/2025
Canopy Growth CAD 18.14M 5.94M Sep/2025
Corcept Therapeutics USD 40.44M 6M Dec/2025
Eli Lilly USD 5.38B 1.12B Dec/2025
Esperion Therapeutics USD 65.07M 12.44M Dec/2025
J&J USD 11.99B 2.37B Dec/2025
Knight Therapeutics CAD 118.13M 8.16M Sep/2025
Lexicon Pharmaceuticals USD 3.08M 714K Dec/2025
Merck USD 4.15B 102M Sep/2025
Nektar Therapeutics USD 15.56M 1.28M Sep/2025
Novartis USD 4.56B 49M Sep/2025
Novartis USD 4.56B 49M Sep/2025
Omeros USD 8.84M 4.42M Jun/2025
Pacira USD 15.15M 2.54M Dec/2025
Pfizer USD 5.02B 142M Sep/2025
Supernus Pharmaceuticals USD 107.8M 813K Dec/2025
TG Therapeutics USD 61.64M 72.38M Sep/2025